Pharmaceutical process chemistry: Evolution of a contemporary data-rich laboratory environment

Journal of Organic Chemistry

Volumn 80, Issue 6, 2015, Pages 2943-2958

  Caron, Stéphane ^a   Thomson, Nicholas M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL LABORATORIES;

CONVENTIONAL EQUIPMENT; EFFICIENT SYNTHESIS; INDUSTRIAL PROCESSS; LABORATORY ENVIRONMENT; MULTI-DISCIPLINARY COLLABORATIONS; ORGANIC CHEMISTRY LABORATORY; PHARMACEUTICAL PROCESS; PROCESS UNDERSTANDING;

LABORATORIES;

ANALYTIC METHOD; CHEMICAL REACTION; COMPLEX FORMATION; CONTROL STRATEGY; COST EFFECTIVENESS ANALYSIS; CRYSTALLIZATION; DRUG INDUSTRY; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROMETRY; LABORATORY; MASS SPECTROMETRY; MEDICINAL CHEMISTRY; MELTING POINT; ORGANIC CHEMISTRY; PARTICLE SIZE; PROCESS OPTIMIZATION; QUALITY CONTROL; REACTION OPTIMIZATION; REVIEW; SCALE UP; SYNTHESIS; ULTRAVIOLET SPECTROSCOPY; VELOCITY; CHEMISTRY; DEVICES;

ORGANIC COMPOUND;

CHEMISTRY, PHARMACEUTICAL; DRUG INDUSTRY; LABORATORIES; ORGANIC CHEMICALS;

EID: 84925358845     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo502879m     Document Type: Review

References (49)

1. Heathcock, C. H. Angew. Chem., Int. Ed. Engl. 1992, 31, 665-681
2. Woodward, R. B.; Bader, F. E.; Bickel, H.; Frey, A. J.; Kierstead, R. W. Tetrahedron 1958, 2, 1-57
3. Butters, M.; Catterick, D.; Craig, A.; Curzons, A.; Dale, D.; Gillmore, A.; Green Stuart, P.; Marziano, I.; Sherlock, J.-P.; White, W. Chem. Rev. 2006, 106, 3002-3027
4. Caron, S., Ed. Practical Synthetic Organic Chemistry: Reactions, Principles, and Techniques; John Wiley & Sons, Inc.: Hoboken, NJ, 2011.
5. Abdel-Magid, A. F.; Caron, S., Eds. Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation; Wiley-Interscience: Hoboken, NJ, 2006.
6. International Conference on Harmonization. International Conference on Harmonization Guideline Q8(R2); Pharmaceutical Development, FDA 2009.
7. am Ende, D.; Bronk, K. S.; Mustakis, J.; OConnor, G.; Santa Maria, C. L.; Nosal, R.; Watson, T. J. N. J. Pharm. Innovation 2007, 2, 71-87
8. Law, J.; Zsoldos, Z.; Simon, A.; Reid, D.; Liu, Y.; Khew, S. Y.; Johnson, A. P.; Major, S.; Wade, R. A.; Ando, H. Y. J. Chem. Inf. Model. 2009, 49, 593-602
9. Thomson, N. M.; De Koning, P. D.; Gillmore, A. T.; Tao, Y. RSC Drug Discovery Ser. 2011, 9, 66-89
10. Bowles, P.; Brenek, S. J.; Caron, S.; Do, N. M.; Drexler, M. T.; Duan, S.; Dube, P.; Hansen, E. C.; Jones, B. P.; Jones, K. N.; Ljubicic, T. A.; Makowski, T. W.; Mustakis, J.; Nelson, J. D.; Olivier, M.; Peng, Z.; Perfect, H. H.; Place, D. W.; Ragan, J. A.; Salisbury, J. J.; Stanchina, C. L.; Vanderplas, B. C.; Webster, M. E.; Weekly, R. M. Org. Process Res. Dev. 2014, 18, 66-81
11. Rubin, A. E.; Tummala, S.; Both, D. A.; Wang, C.; Delaney, E. J. Chem. Rev. 2006, 106, 2794-2810
12. Berliner, M. A.; Cordi, E. M.; Dunetz, J. R.; Price, K. E. Org. Process Res. Dev. 2010, 14, 180-187
13. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925
14. Peng, Z.; Wong, J. W.; Hansen, E. C.; Puchlopek-Dermenci, A. L. A.; Clarke, H. J. Org. Lett. 2014, 16, 860-863
15. Reid, G. L.; Ward, H. W., II; Palm, A. S.; Muteki, K. Am. Pharm. Rev. 2012, 15, 1-12
16. Chanda, A.; Daly, A. M.; Foley, D. A.; LaPack, M. A.; Mukherjee, S.; Orr, J. D.; Reid, G. L.; Thompson, D. R.; Ward, H. W. Org. Process Res. Dev. 2015, 19, 63-83
17. Caron, S. Process Research and Development of a Factor Xa Inhibitor, Stereochemistry Gordon Research Conference, Newport, RI, Jul 29, 2008.
18. Dobo, K. L.; Greene, N.; Cyr, M. O.; Caron, S.; Ku, W. W. Regul. Toxicol. Pharmacol. 2006, 44, 282-293
19. Chekal, B. P.; Guinness, S. M.; Lillie, B. M.; McLaughlin, R. W.; Palmer, C. W.; Post, R. J.; Sieser, J. E.; Singer, R. A.; Sluggett, G. W.; Vaidyanathan, R.; Withbroe, G. J. Org. Process Res. Dev. 2014, 18, 266-274
20. Aitipamula, S.; Banerjee, R.; Bansal, A. K.; Biradha, K.; Cheney, M. L.; Choudhury, A. R.; Desiraju, G. R.; Dikundwar, A. G.; Dubey, R.; Duggirala, N.; Ghogale, P. P.; Ghosh, S.; Goswami, P. K.; Goud, N. R.; Jetti, R. R. K. R.; Karpinski, P.; Kaushik, P.; Kumar, D.; Kumar, V.; Moulton, B.; Mukherjee, A.; Mukherjee, G.; Myerson, A. S.; Puri, V.; Ramanan, A.; Rajamannar, T.; Reddy, C. M.; Rodriguez-Hornedo, N.; Rogers, R. D.; Row, T. N. G.; Sanphui, P.; Shan, N.; Shete, G.; Singh, A.; Sun, C. C.; Swift, J. A.; Thaimattam, R.; Thakur, T. S.; Kumar Thaper, R.; Thomas, S. P.; Tothadi, S.; Vangala, V. R.; Variankaval, N.; Vishweshwar, P.; Weyna, D. R.; Zaworotko, M. J. Cryst. Growth Des. 2012, 12, 2147-2152
21. Newman, A. Org. Process Res. Dev. 2013, 17, 457-471
22. Variankaval, N.; Cote, A. S.; Doherty, M. F. AIChE J. 2008, 54, 1682-1688
23. Miller, J. M.; Collman, B. M.; Greene, L. R.; Grant, D. J. W.; Blackburn, A. C. Pharm. Dev. Technol. 2005, 10, 291-297
24. Aaltonen, J.; Alleso, M.; Mirza, S.; Koradia, V.; Gordon, K. C.; Rantanen, J. Eur. J. Pharm. Biopharm. 2009, 71, 23-37
25. Abramov, Y. A. Org. Process Res. Dev. 2013, 17, 472-485
26. Abramov, Y. A.; Loschen, C.; Klamt, A. J. Pharm. Sci. 2012, 101, 3687-3697
27. Tesconi, M. S.; Feigelson, G.; Strong, H.; Wen, H. WO, 2007005462, 38pp.
28. Chekal, B. P.; Campeta, A. M.; Abramov, Y. A.; Feeder, N.; Glynn, P. P.; McLaughlin, R. W.; Meenan, P. A.; Singer, R. A. Org. Process Res. Dev. 2009, 13, 1327-1337
29. Campeta, A. M.; Chekal, B. P.; Abramov, Y. A.; Meenan, P. A.; Henson, M. J.; Shi, B.; Singer, R. A.; Horspool, K. R. J. Pharm. Sci. 2010, 99, 3874-3886
30. Cornforth, J. Chem. Br. 1975, 11, 432
31. Peng, Z.; Ragan, J. A.; Colon-Cruz, R.; Conway, B. G.; Cordi, E. M.; Leeman, K.; Letendre, L. J.; Ping, L.-J.; Sieser, J. E.; Singer, R. A.; Sluggett, G. W.; Strohmeyer, H.; Vanderplas, B. C.; Blunt, J.; Mawby, N.; Meldrum, K.; Taylor, S. Org. Process Res. Dev. 2014, 18, 36-44
32. International Conference on Harmonization. International Conference on Harmonization Guideline Q3A (R2), Impurities in New Drug Substances. FDA, Rockville, 2008.
33. International Conference on Harmonization. International Conference on Harmonization Guideline M7; Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk, FDA, Rockville, 2008.
34. Dale, D. J.; Draper, J.; Dunn, P. J.; Hughes, M. L.; Hussain, F.; Levett, P. C.; Ward, G. B.; Wood, A. S. Org. Process Res. Dev. 2002, 6, 767-772
35. Mullin, J. W.; Nyvlt, J. Chem. Eng. Sci. 1971, 26, 369-377
36. Beckmann, W. Org. Process Res. Dev. 2000, 4, 372-383
37. Choong, K. L.; Smith, R. Chem. Eng. Sci. 2004, 59, 313-327
38. de Koning, P. D.; McAndrew, D.; Moore, R.; Moses, I. B.; Boyles, D. C.; Kissick, K.; Stanchina, C. L.; Cuthbertson, T.; Kamatani, A.; Rahman, L.; Rodriguez, R.; Urbina, A.; Sandoval, A.; Rose, P. R. Org. Process Res. Dev. 2011, 15, 1018-1026
39. Loschen, C.; Klamt, A. Ind. Eng. Chem. Res. 2012, 51, 14303-14308
40. Bright, R.; Dale, D. J.; Dunn, P. J.; Hussain, F.; Kang, Y.; Mason, C.; Mitchell, J. C.; Snowden, M. J. Org. Process Res. Dev. 2004, 8, 1054-1058
41. Do, N. M.; Olivier, M. A.; Salisbury, J. J.; Wager, C. B. Anal. Chem. 2011, 83, 8766-8771
42. Cai, W.; Chekal, B.; Damon, D.; LaFrance, D.; Leeman, K.; Mojica, C.; Palm, A.; St. Pierre, M.; Sieser, J.; Sutherland, K.; Vaidyanathan, R.; Van Alsten, J.; Vanderplas, B.; Wager, C.; Weisenburger, G.; Withbroe, G.; Yu, S. In Transition Metal-Catalyzed Couplings in Process Chemistry; Magano, J.; Dunetz, J. R., Eds.; Wiley-VCH; Weinheim, 2013; pp 253-266.
43. Cyr, P.; Deng, S. T.; Hawkins, J. M.; Price, K. E. Org. Lett. 2013, 15, 4342-4345
44. Xiang, Y.; Lucas, J.; Van Alsten, J.; Li, B.; Preston, B.; Lovdahl, M.; Hayward, C. M. Am. Pharm. Rev. 2012, 15, 56-61
45. Li, B.; Widlicka, D.; Boucher, S.; Hayward, C.; Lucas, J.; Murray, J. C.; ONeil, B. T.; Pfisterer, D.; Samp, L.; VanAlsten, J.; Xiang, Y.; Young, J. Org. Process Res. Dev. 2012, 16, 2031-2035
46. Dugger, R. W. A QbD Approach to the Process Development of Tofacitinib Citrate, 27th International Organic Process Research and Development Conference, Clearwater, FL, Mar 11, 2013.
47. Am Ende, D. J.; DeVries, K. M.; Clifford, P. J.; Brenek, S. J. Org. Process Res. Dev. 1998, 2, 382-392
48. am Ende, D.; Birch, M.; Brenek, S. J.; Maloney, M. T. Org. Process Res. Dev. 2013, 17, 1345-1358
49. Cordi, E. M. Batch Distillation Predictive Tools for Pharmaceutical Process Development; Aspen Webinar, Houston, TX, 2009.